Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Safranal is a major volatile compound derived from saffron (Crocus sativus L.), and has been investigated for its effects on the central nervous system, particularly its interactions with the GABAergic system. Several preclinical studies indicate that safranal may modulate the GABA_A receptor complex. For example, animal models have demonstrated that safranal possesses anticonvulsant, anxiolytic, and sedative properties—effects commonly mediated by enhancement of GABAergic neurotransmission. In rodent studies, safranal has shown protective effects against chemically-induced seizures and has potentiated the action of known GABAergic drugs such as diazepam, suggesting a possible positive modulation of GABA_A receptors.

However, the majority of evidence comes from animal models or in vitro studies. While these findings are promising and provide a scientific rationale for its potential to support the GABA system, there is a lack of robust clinical trials in humans directly examining safranal’s effects on GABAergic neurotransmission or related conditions such as anxiety or epilepsy. Thus, while there is scientific interest and preliminary support for safranal’s role in modulating the GABA system, the current strength of evidence is moderate and primarily preclinical.

More about Safranal
More about GABA

Other ingredients that support GABA

Other body systems supported by Safranal

Products containing Safranal